The appearance of BCR/ABL1 in AML has been described in combination with different class II aberrations such as CBFβ/MYH11, RUNX1/RUNX1T1, PML/RARa, and NPM1. This evidence concerns the gene RUNX1 and acute myeloid leukemia.